HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: M800410-MCP200v1 8/7/1719    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Burande, C. F. Articles by Lutz, P. G. Search for Related Content PubMed PubMed Citation Articles by Burande, C. F. Articles by Lutz, P. G. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 8:1719-1727, 2009.
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

A Label-free Quantitative Proteomics Strategy to Identify E3 Ubiquitin Ligase Substrates Targeted to Proteasome Degradation^*,

Clara F. Burande, Mélina L. Heuzé, Isabelle Lamsoul^¶, Bernard Monsarrat, Sandrine Uttenweiler-Joseph^|| and Pierre G. Lutz^**

From the Institut de Pharmacologie et de Biologie Structurale (IPBS) CNRS 205 Route de Narbonne and IPBS, Université Paul Sabatier Université de Toulouse F-31077 Toulouse France

The ubiquitin-proteasome system is a central mechanism for controlled proteolysis that regulates numerous cellular processes in eukaryotes. As such, defects in this system can contribute to disease pathogenesis. In this pathway, E3 ubiquitin ligases provide platforms for binding specific substrates, thereby coordinating their ubiquitylation and subsequent degradation by the proteasome. Despite the identification of many E3 ubiquitin ligases, the identities of their specific substrates are still largely unresolved. The ankyrin repeat-containing protein with a suppressor of cytokine signaling box 2 (ASB2) gene that we initially identified as a retinoic acid-response gene in acute promyelocytic leukemia cells encodes the specificity subunit of an E3 ubiquitin ligase complex that is involved in hematopoietic cell differentiation. We have recently identified filamin A and filamin B as the first ASB2 targets and shown that ASB2 triggers ubiquitylation and proteasome-mediated degradation of these proteins. Here a global quantitative proteomics strategy is provided to identify substrates of E3 ubiquitin ligases targeted to proteasomal degradation. Indeed we used label-free methods for quantifying proteins identified by shotgun proteomics in extracts of cells expressing wild-type ASB2 or an E3 ubiquitin ligase-defective mutant of ASB2 under the control of an inducible promoter. Measurements of spectral count and mass spectrometric signal intensity demonstrated a drastic decrease of filamin A and filamin B in myeloid leukemia cells expressing wild-type ASB2 compared with cells expressing an E3 ubiquitin ligase-defective mutant of ASB2. Altogether we provide an original strategy that enables identification of E3 ubiquitin ligase substrates that have to be degraded.

** To whom correspondence may be addressed: Inst. de Pharmacologie et de Biologie Structurale, Cancer Biology Dept., 205 Route de Narbonne, F-31077 Toulouse, France. Tel.: 33-561-175-471; Fax: 33-561-175-994; E-mail: Pierre.Lutz{at}ipbs.fr.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?